Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1989 Jul 8;299(6691):81–85. doi: 10.1136/bmj.299.6691.81

Risk factors and 25 year risk of coronary heart disease in a male population with a high incidence of the disease: the Finnish cohorts of the seven countries study.

J Pekkanen 1, A Nissinen 1, P Puska 1, S Punsar 1, M J Karvonen 1
PMCID: PMC1837141  PMID: 2504340

Abstract

OBJECTIVE--To assess the efficacy of high serum cholesterol concentration, raised blood pressure, and smoking as predictors of coronary heart disease. DESIGN--Prospective cohort study of middle aged men conducted over 25 years. SETTING--Finish components of an ongoing international study (seven countries study). PARTICIPANTS--1520 Men who at age 40-59 in 1959 were free of clinically evident heart disease. INTERVENTIONS--At each follow up visit a detailed medical examination including resting electrocardiography was performed, blood pressure and serum total cholesterol concentration were measured, and smoking was assessed. MEASUREMENTS AND MAIN RESULTS--825 Deaths (54% of participants) occurred during follow up, of which 335 were due to coronary heart disease. The hazard ratio for death from coronary heart disease with respect to risk factors at entry were: for serum cholesterol concentrations above 8.4 mmol/l v below 5.2 mmol/l, 2.68 (95% confidence interval 1.62 to 4.42); for systolic blood pressure in the highest quintile v that in the lowest quintile, 2.46 (1.72 to 3.50); and for smoking 10 or more cigarettes daily v never smoking, 1.95 (1.36 to 2.79). The hazard ratios with respect to cholesterol concentrations and blood pressure remained constant during follow up but the ratio with respect to smoking diminished, mainly owing to men giving up the habit. The estimated conditional probability of a 50 year old man dying of coronary heart disease in the next 25 years ranged from 12% among those with the most favourable risk factor profile to 75% among those with the least favourable profile. CONCLUSIONS--High risk factor levels (as determined in this study) in middle aged men may greatly increase the absolute probability of death from coronary heart disease when the period of study is relevant to the human life span.

Full text

PDF
81

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABEL L. L., LEVY B. B., BRODIE B. B., KENDALL F. E. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952 Mar;195(1):357–366. [PubMed] [Google Scholar]
  2. ANDERSON J. T., KEYS A. Cholesterol in serum and lipoprotein fractions; its measurement and stability. Clin Chem. 1956 Jun;2(3):145–159. [PubMed] [Google Scholar]
  3. BLACKBURN H., KEYS A., SIMONSON E., RAUTAHARJU P., PUNSAR S. The electrocardiogram in population studies. A classification system. Circulation. 1960 Jun;21:1160–1175. doi: 10.1161/01.cir.21.6.1160. [DOI] [PubMed] [Google Scholar]
  4. Doll R., Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J. 1976 Dec 25;2(6051):1525–1536. doi: 10.1136/bmj.2.6051.1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dyer A. R. An analysis of the relationship of systolic blood pressure, serum cholesterol, and smoking to 14-year mortality in the Chicago Peoples Gas Company Study- II. Coronary and cardiovascular-renal mortality in two competing risk models. J Chronic Dis. 1975 Dec;28(11-12):571–578. doi: 10.1016/0021-9681(75)90070-3. [DOI] [PubMed] [Google Scholar]
  6. Frick M. H., Elo O., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P., Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. doi: 10.1056/NEJM198711123172001. [DOI] [PubMed] [Google Scholar]
  7. Gofman J. W., Young W., Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation. 1966 Oct;34(4):679–697. doi: 10.1161/01.cir.34.4.679. [DOI] [PubMed] [Google Scholar]
  8. HAMMOND E. C., HORN D. Smoking and death rates; report on forty-four months of follow-up of 187,783 men. I. Total mortality. J Am Med Assoc. 1958 Mar 8;166(10):1159–1172. doi: 10.1001/jama.1958.02990100047009. [DOI] [PubMed] [Google Scholar]
  9. Holford T. R. The analysis of rates and of survivorship using log-linear models. Biometrics. 1980 Jun;36(2):299–305. [PubMed] [Google Scholar]
  10. Hollander W. Role of hypertension in atherosclerosis and cardiovascular disease. Am J Cardiol. 1976 Nov 23;38(6):786–800. doi: 10.1016/0002-9149(76)90357-x. [DOI] [PubMed] [Google Scholar]
  11. Hubert H. B., Feinleib M., McNamara P. M., Castelli W. P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983 May;67(5):968–977. doi: 10.1161/01.cir.67.5.968. [DOI] [PubMed] [Google Scholar]
  12. Karvonen M. J., Punsar S. Sodium excretion and blood pressure of West and East Finns. Acta Med Scand. 1977;202(6):501–507. doi: 10.1111/j.0954-6820.1977.tb16872.x. [DOI] [PubMed] [Google Scholar]
  13. Keys A., Aravanis C., Blackburn H. W., Van Buchem F. S., Buzina R., Djordjević B. D., Dontas A. S., Fidanza F., Karvonen M. J., Kimura N. Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand Suppl. 1966;460:1–392. [PubMed] [Google Scholar]
  14. Kromhout D., Bosschieter E. B., Drijver M., de Lezenne Coulander C. Serum cholesterol and 25-year incidence of and mortality from myocardial infarction and cancer. The Zutphen Study. Arch Intern Med. 1988 May;148(5):1051–1055. [PubMed] [Google Scholar]
  15. Martin M. J., Hulley S. B., Browner W. S., Kuller L. H., Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986 Oct 25;2(8513):933–936. doi: 10.1016/s0140-6736(86)90597-0. [DOI] [PubMed] [Google Scholar]
  16. Nissinen A., Kivela S. L., Pekkanen J., Tuomilehto J., Kostiainen E., Piippo H., Lammi U. K., Kaarsalo E., Romo M., Punsar S. Levels of some biological risk indicators among elderly men in Finland. Age Ageing. 1986 Jul;15(4):203–211. doi: 10.1093/ageing/15.4.203. [DOI] [PubMed] [Google Scholar]
  17. Oliver M. F. Prevention of coronary heart disease--propaganda, promises, problems, and prospects. Circulation. 1986 Jan;73(1):1–9. doi: 10.1161/01.cir.73.1.1. [DOI] [PubMed] [Google Scholar]
  18. Punsar S., Pyöräla K., Siltanen P. Classification of electrocardiographic S-T segment changes in epidemiological studies of coronary heart disease. Preliminary evaluation of a new, modified classification, with particular reference to the prognostic significance of different types of S-T segment changes. Ann Med Intern Fenn. 1968;57(2):53–63. [PubMed] [Google Scholar]
  19. Pyörälä K., Salonen J. T., Valkonen T. Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology. 1985;72(1-2):35–51. doi: 10.1159/000173839. [DOI] [PubMed] [Google Scholar]
  20. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981 Jun 6;282(6279):1847–1851. doi: 10.1136/bmj.282.6279.1847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Steinberg D. Lipoproteins and atherosclerosis. A look back and a look ahead. Arteriosclerosis. 1983 Jul-Aug;3(4):283–301. doi: 10.1161/01.atv.3.4.283. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES